Venetoclax w Rituximab progressed the furthest  Phase 3 Data shows the combination is superior

Venetoclax w Rituximab progressed the furthest Phase 3 Data shows the combination is superior

hematologydebates

1 year
27 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:
Matthew S. Davids, MD, MMSc, talks about how Venetoclax w Rituximab progressed the furthest Phase 3 Data shows the combination is superior Imedex Great Debates 2018.
Up Next Autoplay